Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Advanced Prostate Cancer × Leuprolide × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 37 Breast Neoplasms 6 Neoplasms 2 Breast Neoplasms, Male 2 Sexual Dysfunction, Physiological 1 Neoplasm Metastasis 1 Leiomyoma 1 Breast Cancer Invasive 1 Advanced Prostate Cancer 1 Adenocarcinoma 1

Interventions

Leuprolide 1 Goserelin 1 Docetaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06490328 2024-07-08

Efficacy and Safety of DKF-MA102 in Patients With Prostate Cancer

Dongkook Pharmaceutical Co., Ltd.

Phase 3 Recruiting

Advanced Prostate Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡